Frederick Beddingfield III, Chief Medical Officer at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 110,638 shares at $74.91 ($8.3M) on 2015-09-24, disclosed to the SEC on 2015-09-28.
Open-market sale of $8.3M KYTH by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KYTH | SELL | 2015-04-30 | $93K | — | Filing → |